Genflow Biosciences plc (GENFF)

Genflow Biosciences Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2021
Cash & Equivalents	0.28	0.68	2.36	0.22	0.25
Cash & Short-Term Investments	0.28	0.68	2.36	0.22	0.25
Cash Growth	-59.26%	-70.97%	951.87%	-11.89%	-
Other Receivables	0.04	0.34	0.13	0.02	0.02
Receivables	0.04	0.34	0.13	0.02	0.02
Prepaid Expenses	0.07	0.04	0.13	0.03	0.01
Total Current Assets	0.38	1.07	2.62	0.28	0.28
Property, Plant & Equipment	0	0	0	-	-
Total Assets	0.39	1.07	2.62	0.28	0.28
Accounts Payable	0.37	0.25	0.08	0.04	0.05
Accrued Expenses	0.07	0.06	0.16	0.17	0.01
Current Unearned Revenue	0.33	-	-	-	-
Other Current Liabilities	0.02	0.03	0.01	0.01	-
Total Current Liabilities	0.79	0.35	0.25	0.22	0.06
Total Liabilities	0.79	0.35	0.25	0.22	0.06
Common Stock	0.1	0.09	0.09	0.07	0
Additional Paid-In Capital	4.83	4.19	4.19	0.63	0.25
Retained Earnings	-5.59	-3.77	-2.14	-0.81	-0.11
Comprehensive Income & Other	0.25	0.22	0.23	0.16	0.07
Shareholders' Equity	-0.4	0.73	2.37	0.06	0.22
Total Liabilities & Equity	0.39	1.07	2.62	0.28	0.28
Net Cash (Debt)	0.28	0.68	2.36	0.22	0.25
Net Cash Growth	-59.26%	-70.97%	951.87%	-11.89%	-
Net Cash Per Share	0.00	0.00	0.01	0.00	0.32
Filing Date Shares Outstanding	349.71	292.51	292.51	292.51	244.57
Total Common Shares Outstanding	349.71	292.51	292.51	244.57	6.31
Working Capital	-0.41	0.72	2.36	0.06	0.22
Book Value Per Share	-0.00	0.00	0.01	0.00	0.03
Tangible Book Value	-0.4	0.73	2.37	0.06	0.22
Tangible Book Value Per Share	-0.00	0.00	0.01	0.00	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.